Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use
← catalyst calendarSponsored by Pfizer (industry) · PFE — their whole pipeline →.
Phase
Phase 4
Status
Completed
Study type
Interventional
Design
Randomized · Quadruple · Treatment
Enrollment
813actual
Sites
93
Countries
Australia, Austria, Belgium +12
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2022-10-18 | actual | When the study began enrolling |
| Primary completion | 2025-03-10 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-06-10 | actual | The whole study's end, after follow-up |
| First posted | 2022-08-22 | actual | When this record first appeared on the registry |
| Results posted | 2026-04-21 | actual | When the sponsor posted results to the registry |
| Record updated | 2026-04-21 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Migraine
Interventions
- Drug: Rimegepant
- Drug: Placebo
- Drug: Rimegepant
Primary outcome
what the primary-completion date above is the date OFPercentage of Participants With Pain Relief at 2 Hours Post-Dose: DBT Phase
measured At 2 hours post-dose
Posted documents
hosted by the registry — we link, never re-serveStudy Protocolposted 2024-09-05 · 15.0 MB · Prot_000.pdf
Statistical Analysis Planposted 2025-05-15 · 12.0 MB · SAP_001.pdf
Publications
- PMID 41930741 — linked by the registry
- PMID 41255093 — linked by the registry
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Permalink · PFE's whole pipeline · Catalyst calendar · Every registered study · What changed